Medicine
Suprane 240 mL/240 mL inhalation solution
Suprane 240 mL/240 mL inhalation solution is a prescription medicine containing Desflurane for inhalation use, marketed by Baxter Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, 15°-30°C (59°-86°F).
Key facts
- Active ingredient (INN)
- Desflurane
- Brand
- Suprane
- Strength
- 240 mL/240 mL
- Dosage form
- Inhalation solution
- Route
- Inhalation
- Packs
- 6 bottles, 1 bottle and 1 more
- Marketing authorisation holder
- Baxter Healthcare
- Manufacturers
- Baxter HealthcareHenry Schein
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, 15°-30°C (59°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01AB07 Desflurane
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 September 1992
- Identifiers
- RxCUI 208919, 562366DailyMed set ID 7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5, a3e4c8e5-bff0-4a8f-8401-e9866c846ee2, 3fe3d468-d283-4dd0-a1a7-29291a9b2d0b +1NDC 10019-646, 0404-9961, 10019-641 +1Application NDA020118
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 bottle in 1 carton / 240 mL in 1 bottle | 10019-641-34 | Baxter Healthcare | 18 September 1992 |
| 6 bottle in 1 carton / 240 mL in 1 bottle | 10019-644-34 | Baxter Healthcare | 18 September 1992 |
| 6 bottle in 1 carton / 240 mL in 1 bottle | 10019-646-34 | Baxter Healthcare | 18 September 1992 |
| 1 bottle in 1 bag / 240 mL in 1 bottle | 0404-9961-25 | Henry Schein | 12 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 September 1992 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Desflurane 240 mL/240 mL inhalation solution.
Clinical summary
Desflurane is a general anesthetic indicated for induction and/or maintenance of anesthesia in adults, among other approved uses. It is available as inhalation solution. MedsAcross supplies Desflurane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DesfluraneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SUPRANE prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Suprane 240 mL/240 mL inhalation solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.